ERβ regulation of NF-kB activation in prostate cancer is mediated by HIF-1

Area of Science:

• Oncology
• Molecular Biology
• Endocrinology

Background:

• Estrogen receptor beta (ERβ) expression inversely correlates with p65 in prostate cancer.
• ERβ is known to inhibit NF-κB activation, but the mechanism remains unclear.

Purpose of the Study:

• To elucidate the mechanism by which ERβ regulates NF-κB signaling in prostate cancer.
• To investigate the role of ERβ, HIF-1, and IKKβ in prostate cancer progression.

Main Methods:

• Analysis of ERβ and p65 expression in prostate carcinomas.
• Demonstration of ERβ's role in repressing NF-κB p65 expression and nuclear translocation.
• Investigation of HIF-1's involvement in ERβ-mediated NF-κB regulation.
• Correlation analysis in ERβ knockout mice, high-grade tumors, and prostate cancer databases.

Main Results:

• ERβ acts as a gatekeeper by repressing NF-κB p65 expression and nuclear translocation.
• HIF-1 mediates ERβ's regulation of NF-κB signaling.
• Loss of ERβ or hypoxia stabilizes HIF-1α, driving IKKβ transcription.
• Increased IKKβ expression correlates with elevated phospho-IκBα and p65 nuclear translocation in ERβ-ablated cells.

Conclusions:

• ERβ prevents NF-κB activation through a novel mechanism involving HIF-1 and IKKβ.
• Loss of ERβ expression is linked to chronic prostate inflammation and the development of high-grade prostate cancer.